Aortic, CMS and TAVR - Cardiovascular Update

Edwards Acquires JenaValve and Endotronix, Expands into Aortic Regurgitation and Heart Failure

CardiacWire

JULY 28, 2024

Edwards Lifesciences is going all-in on structural heart and heart failure, acquiring aortic valve-maker JenaValve Technology and implantable heart failure monitor company Endotronix for $1.2B The post Edwards Acquires JenaValve and Endotronix, Expands into Aortic Regurgitation and Heart Failure appeared first on Cardiac Wire.

Heart Failure

Heart Failure Aortic TAVR Critical Care

New Legislation Speeds Progress on Patient Access to New Technologies

Society of Thoracic Surgeons - Technology

OCTOBER 21, 2021

For example, we have a lot of meaningful data on outcomes from CABG procedures and transcatheter aortic valve replacement in the short term. “This legislation, if passed, would help us see the bigger picture and allow us to design treatment strategies that would offer the best long-term outcomes for our patients,” said Alan M.

Technology

Technology Coronary Artery Bypass Graft Cardiothoracic Aortic valve

Edwards Acquires JenaValve and Endotronix, Expands into Aortic Regurgitation and Heart Failure

New Legislation Speeds Progress on Patient Access to New Technologies

Stay Connected